Sebaceous gland carcinoma (SGC) and some poorly differentiated squamous cell carcinomas (SC) of the eyelid may have overlapping clinical and histopathologic features, leading to potential misdiagnosis and delayed treatment. The authors developed a deep…
Continue Reading
Long COVID poses a significant disease burden globally, but its heterogeneous presentation and unreliable coding practices render it difficult to study. Developing efficient phenotyping algorithms is crucial to enabling risk prediction and effective management…
Continue Reading
This multicenter retrospective study developed and validated an AI driven model for automated segmentation and quantitative evaluation of meibomian glands using infrared meibography images acquired by the Keratograph 5M device. A total of 1350…
Continue Reading
Symptom monitoring using electronic patient-reported outcomes (ePROs) has demonstrated benefits for patients with cancer, yet the systematic effects for lung cancer remains unknown. This study performed a literature search in Medline, Embase, Cochrane library,…
Continue Reading
What You Should Know:
– Bluesight, a leader in hospital intelligence solutions released its 2025 Diversion Trends Report, a comprehensive analysis highlighting the significant impact of software on the monitoring, prevention, and identification of controlled…
Continue Reading
This study introduces a Bayesian multidimensional hierarchical item response theory (MHIRT) model to improve patient-reported outcome (PRO) assessments in total knee arthroplasty (TKA). Traditional unidimensional scoring fails to capture the multifaceted nature of recovery….
Continue Reading
Welcome to the June 2025 edition of Digital Health Digest!Stay on the cutting edge of healthcare technology with our top stories this month. From multimillion-dollar funding rounds to AI assistants transforming workflows, these innovations…
Continue Reading
A bankruptcy judge has approved the sale of 23andMe to the nonprofit TTAM Research Institute, owned by cofounder and former CEO of 23andMe Anne Wojcicki, thereby ensuring that the DNA of the company’s customers will…
Continue Reading
We reviewed 1016 FDA authorizations of AI/ML-enabled medical devices to develop a taxonomy capturing key variations in clinical and AI-related features. Quantitative image analysis remains the most common application, but its relative proportion has…
Continue Reading
Microsoft has made a revolutionary leap in artificial intelligence healthcare technology, with CEO Mustafa Suleyman declaring that the tech giant has taken “a genuine step toward medical superintelligence.” This groundbreaking development represents a significant…
Continue Reading
